Edesa Biotech Inc reports results for the quarter ended in March - Earnings Summary

Edesa Biotech

14/05/2021 23:15

* Edesa Biotech Inc  EDSA.OQ  reported a quarterly adjusted loss
of 81 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 29
cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Edesa Biotech Inc's reported EPS for the quarter was a loss
of 19 cents​.
* The mean earnings estimate of analysts had fallen by
about 7.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Edesa Biotech Inc shares had risen by 8.7% this quarter and
gained 38.1% so far this year.
* The company reported a quarterly loss of $2.26 million.
* Wall Street's median 12-month price target for Edesa Biotech
Inc is $17.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 10:15 p.m. GMT.
​All figures in US dollars